Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesofensine in early Parkinson's disease (SCEPTRE)
NCT00148486Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tesofensine in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started Jun 2003; status: completed.
02
Drugs
tesofensine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00148486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148486.